कृपया अन्य खोज का प्रयास करें
EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company’s pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Goran A. Ando | 74 | 2018 | Independent Non-Executive Chairman |
Jay S. Duker | 64 | 2020 | President, CEO & Director |
Nancy S. Lurker | 66 | 2016 | Executive Vice-Chairman |
Anat Loewenstein | - | 2023 | Member of Executive Scientific Advisory Board |
Anthony P. Adamis | 64 | 2022 | Independent Director |
Karen Zaderej | 61 | 2022 | Independent Director |
Stuart Duty | 58 | 2023 | Independent Director |
Wendy F. DiCicco | 57 | 2019 | Independent Director |
David Robert Guyer | 64 | 2019 | Independent Director |
Charles C. Wykoff | - | 2021 | Co-Chair of Scientific Advisory Board |
Rishi P. Singh | - | 2021 | Member of Executive Scientific Advisory Board |
Glenn J. Jaffe | - | 2021 | Member of Executive Scientific Advisory Board |
Allen C. Ho | - | 2024 | Member of Scientific Advisory Board |
David S. Boyer | - | 2021 | Member of Executive Scientific Advisory Board |
Carl D. Regillo | - | 2021 | Co- Chairman of Scientific Advisory Board |
Anna Kluczewska | - | - | CEO of AION Diagnostics Ltd, President of AION Diagnostics Ltd and Director of AION Diagnostics Ltd |
Ye Liu | 52 | 2020 | Director |
Sophie J. Bakri | - | 2021 | Member of Executive Scientific Advisory Board |
Usha Chakravarthy | - | 2024 | Member of Scientific Advisory Board |
Frank G. Holz | - | 2024 | Member of Scientific Advisory Board |
John B. Landis | 71 | 2018 | Interim Head of R&D and Director |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है